<code id='A89302F336'></code><style id='A89302F336'></style>
    • <acronym id='A89302F336'></acronym>
      <center id='A89302F336'><center id='A89302F336'><tfoot id='A89302F336'></tfoot></center><abbr id='A89302F336'><dir id='A89302F336'><tfoot id='A89302F336'></tfoot><noframes id='A89302F336'>

    • <optgroup id='A89302F336'><strike id='A89302F336'><sup id='A89302F336'></sup></strike><code id='A89302F336'></code></optgroup>
        1. <b id='A89302F336'><label id='A89302F336'><select id='A89302F336'><dt id='A89302F336'><span id='A89302F336'></span></dt></select></label></b><u id='A89302F336'></u>
          <i id='A89302F336'><strike id='A89302F336'><tt id='A89302F336'><pre id='A89302F336'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:7
          Calling Bullshit course University of Washington
          Screenshot via callingbullshit.org

          Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

          Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

          advertisement

          The class website and colorful syllabus went online last month and almost instantly went viral.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Prior authorization reform is both possible and imperative
          Prior authorization reform is both possible and imperative

          AdobeImaginethisscene:Youareacancerpatientalreadynavigatingfearanduncertaintyaroundyourtreatment,whe

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          House looks to weaken Medicare negotiation

          TheHouseofRepresentativesishavingahearingontwobillsthatcouldweakenMedicare'sdrugpricenegotiationproc